Since our inception in August 2016 we have advised corporate clients and raised more than SEK 7 billion from global specialist investors, blue chip pension funds and renown mutual funds. Before taking on a fund-raising advisory assignment we perform extensive due diligence to make sure that the companies we work with are of such high quality that we can leverage our global network of sophisticated investors. We take pride in executing transactions to help allocating capital to promising new life-saving efforts.
Infant Bacterial Therapeutics
SEK 545 M, directed share issue and rights issue